Skip to content

Author

H. Nakagawa

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

High Lipoprotein(a) Is a Predictor of Adverse Events and Heart Failure in Patients With Acute Myocardial Infarction.

Elevated Lp(a) is independently associated with adverse cardiovascular outcomes after AMI, particularly HF, and measurement of Lp(a) may improve risk stratification after AMI and help identify patients at high risk of developing HF, including HFpEF.

Yang Wang, T. Ueda, A. Okamura et al. · 0 citations
Open access Sep 2026

Reversible osimertinib‑associated heart failure mimicking cancer recurrence in EGFR ‑mutated non‑small cell lung cancer after pneumonectomy: A case report

. Osimertinib is a third‑generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor widely used in patients with EGFR mutation‑positive non‑small cell lung cancer (NSCLC). Although generally well tolerated, clinically notable cardiovascular toxicities, including heart failure, have been recognized. Th...

Hirona Yokoyama, N. Hara, R. Sasaki et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.